Diminazene attenuates pulmonary hypertension and improves angiogenic progenitor cell functions in experimental models. - Wikidata - awgldk - TriplyDB

Diminazene attenuates pulmonary hypertension and improves angiogenic progenitor cell functions in experimental models.

Diminazene attenuates pulmonary hypertension and improves angiogenic progenitor cell functions in experimental models.

http://www.wikidata.org/entity/Q37070077

about

Neuroprotective mechanisms of the ACE2-angiotensin-(1-7)-Mas axis in stroke Upregulation of Angiotensin (1-7)-Mediated Signaling Preserves Endothelial Function Through Reducing Oxidative Stress in Diabetes.Oral delivery of Angiotensin-converting enzyme 2 and Angiotensin-(1-7) bioencapsulated in plant cells attenuates pulmonary hypertension.Update in pulmonary vascular diseases 2013.Angiotensin-converting enzyme 2 (ACE2) activator diminazene aceturate ameliorates endotoxin-induced uveitis in mice Neuroinflammation in pulmonary hypertension: concept, facts, and relevance.Angiotensin-converting enzyme 2 decreases formation and severity of angiotensin II-induced abdominal aortic aneurysms Short-term treatment with diminazene aceturate ameliorates the reduction in kidney ACE2 activity in rats with subtotal nephrectomy.Selective activation of angiotensin AT2 receptors attenuates progression of pulmonary hypertension and inhibits cardiopulmonary fibrosis.ACE2 and Microbiota: Emerging Targets for Cardiopulmonary Disease Therapy Diminazene Aceturate Improves Cardiac Fibrosis and Diastolic Dysfunction in Rats with Kidney Disease.ACE2/Ang-(1-7)/Mas axis stimulates vascular repair-relevant functions of CD34+ cells.Angiotensin-converting enzyme 2 activator diminazene aceturate prevents lipopolysaccharide-induced inflammation by inhibiting MAPK and NF-κB pathways in human retinal pigment epithelium.Angiotensin converting enzyme versus angiotensin converting enzyme-2 selectivity of MLN-4760 and DX600 in human and murine bone marrow-derived cells.Increasing brain angiotensin converting enzyme 2 activity decreases anxiety-like behavior in male mice by activating central Mas receptors.Diminazene aceturate improves autonomic modulation in pulmonary hypertension Role of the ACE2/Angiotensin 1-7 Axis of the Renin-Angiotensin System in Heart Failure New agents modulating the renin-angiotensin-aldosterone system-Will there be a new therapeutic option?Angiotensin-converting enzyme 2-independent action of presumed angiotensin-converting enzyme 2 activators: studies in vivo, ex vivo, and in vitro Endothelial cell regulation of pulmonary vascular tone, inflammation, and coagulation.Future drug discovery in renin-angiotensin-aldosterone system intervention.Endothelial dysfunction and vascular disease - a 30th anniversary update.The vasoprotective axes of the renin-angiotensin system: Physiological relevance and therapeutic implications in cardiovascular, hypertensive and kidney diseases.Diminazene enhances stability of atherosclerotic plaques in ApoE-deficient mice.Diminazene aceturate enhances angiotensin-converting enzyme 2 activity and attenuates ischemia-induced cardiac pathophysiology.Activation of angiotensin-converting enzyme 2 improves cardiac electrical changes in ventricular repolarization in streptozotocin-induced hyperglycaemic rats.Beneficial Effects Of Angiotensin-(1-7) On Cd34 + Cells From Heart Failure Patients.Coupling corticotropin-releasing-hormone and angiotensin converting enzyme 2 dampens stress responsiveness in male mice.ACE2-angiotensin-(1-7)-Mas axis might be a promising therapeutic target for pulmonary arterial hypertension.The Selective Angiotensin II Type 2 Receptor Agonist, Compound 21, Attenuates the Progression of Lung Fibrosis and Pulmonary Hypertension in an Experimental Model of Bleomycin-Induced Lung Injury.A novel ACE2 activator reduces monocrotaline-induced pulmonary hypertension by suppressing the JAK/STAT and TGF-β cascades with restored caveolin-1 expression.rhACE2 Therapy Modifies Bleomycin-Induced Pulmonary Hypertension via Rescue of Vascular Remodeling.The small molecule drug diminazene aceturate inhibits liver injury and biliary fibrosis in mice

P2860

Q26998948-067132C7-FDE4-49CC-A9BE-671B804F91D3 Q27308039-E35FB7A2-98A7-4519-95A0-246F64599938 Q30600509-471BDB1F-5C7F-4D19-A62D-961EA64E2B4B Q33732209-DB9501BC-0F3F-4D09-9A4F-20BFD6E434DD Q33773490-D83BA028-58D9-4756-AA44-937B62955845 Q34205701-69559565-C5F1-400F-97E0-55C19485DA43 Q34606642-095900D8-A119-42B6-88A4-9C921723B128 Q35192530-DAD360B5-B449-46DE-9F5A-B7A2A249D2D5 Q35484295-93B1C237-1533-46F3-A252-B2CFE747FD08 Q35760437-AA84E869-214B-44F8-9BF0-5D8138F4A0DA Q36116045-55012CE7-612D-4F43-A401-F6988758D4EC Q36339485-41CF262A-6B0A-453B-BC0F-5A85CCECF291 Q36565868-289A6CB2-4034-498A-BB3F-8A5A4E90D505 Q36720678-F4A3534E-96B0-4C4C-8BF8-15E6B2BC678C Q36917960-E33CFCFE-082B-4207-B589-00F0AF784F20 Q37016860-3042955E-3C91-4F33-AA6F-B874280B9A72 Q37081415-D314DE18-319D-4AF8-B6B7-572F8501BDD3 Q37347190-8BC9DCA3-C19C-4B86-A60A-829A76F6F398 Q37731227-F3E3640A-D8A7-4B91-8F0A-8FD3D9750AED Q38423843-99D0C009-2758-4F70-953B-9CAB0A828087 Q38679303-45A7D2CE-9009-4A80-8805-B5296C73D023 Q38680112-2471D85C-1623-4860-B286-B8BE215A2D7C Q39376362-F3A39232-8FA2-4AEA-9D7D-BBDD0B826013 Q41572699-F4887792-0D69-4609-A910-F4438FBAC529 Q41780755-603BCF50-3C6E-4ADE-91E2-E673577F0580 Q45193547-94A820BE-8412-4431-8F5C-46ED8EF7CC5C Q47592483-660E7213-9478-45BF-B4B5-7FAA6915C1D3 Q47845003-6D71116F-F4C2-46DA-A0FA-8FE6F6DD64D9 Q50588472-6820B20C-B0E3-4962-8154-1DD09DC638B5 Q52595214-16097739-258B-4C56-B7B1-58BCF7B398AA Q52654089-E91B4274-9755-4FE5-8D89-3428F489549A Q55343523-D6219103-E97B-4269-B88A-C96731F0A52B Q57115264-07181CC4-DC00-4A2D-934C-D798424A6DF9

P2860

Diminazene attenuates pulmonary hypertension and improves angiogenic progenitor cell functions in experimental models.

http://www.wikidata.org/entity/Q37070077

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 31 January 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Diminazene attenuates pulmonar ...... ctions in experimental models.

@en

Diminazene attenuates pulmonar ...... ctions in experimental models.

@nl

type

label

Diminazene attenuates pulmonar ...... ctions in experimental models.

@en

Diminazene attenuates pulmonar ...... ctions in experimental models.

@nl

prefLabel

Diminazene attenuates pulmonar ...... ctions in experimental models.

@en

Diminazene attenuates pulmonar ...... ctions in experimental models.

@nl

P1433

Q37070077-E5FAF7D9-135A-45A5-95BF-04CD69335F82

P1476

Q37070077-E5B871A0-35CB-44C3-BB10-9A80A13BBE9F

P2093

Q37070077-02442337-4691-4178-B8C1-AE2368A062A5

Q37070077-07AB25CB-7AF2-4BCB-9B11-37F6965ABC1F

Q37070077-357C02BD-E7C9-4295-AEFF-4E9C4F2D9A26

Q37070077-36DDD87C-D4DF-49E4-8155-CB7C1CEB7502

Q37070077-4052B2FC-E49F-4570-B733-C4ABF0FC316B

Q37070077-4308B4F6-91A8-45EF-9B1E-F75061CFFE9A

Q37070077-43800275-0E02-4FD5-97B4-EF001F338666

Q37070077-4660A5A2-D002-4724-B827-BD732D29302C

Q37070077-48403A13-2BF6-4EC4-92CF-CF701167785F

Q37070077-4FD3DBE7-8153-493D-AFB6-CE3F78BD3F1A

P2860

Q37070077-01E04118-9C9B-47B4-AF68-313BBBC5D1C3

Q37070077-04F1B800-1F4E-4C76-B9BC-D54EE7D0E84B

Q37070077-07D753F1-48E4-4401-A6AD-5CAEEA91E000

Q37070077-0D6B4CF7-2976-469B-8EA6-9B544FA61108

Q37070077-0FB36275-7ECE-44FB-A317-78CCE1C63141

Q37070077-10004636-E8E0-4B9F-BCE2-2304DB361994

Q37070077-160C81C1-E9EC-4E23-81BB-AA99ADC31438

Q37070077-16483CED-F0E5-45FE-B853-CCB28F10A0E3

Q37070077-1687EEFA-6065-4A24-8C1E-61B513CAAA1E

Q37070077-22ED60C2-4BCF-4D4F-B2C7-6579F5AFB591

P304

Q37070077-5BDE73ED-AFFC-4AF4-BD5A-AB7C0AFC7BCA

P31

Q37070077-A4EA0145-5D54-4AAF-B68C-9F537CC39DB2

P356

Q37070077-157E900B-5EB5-4E3D-AAF1-6FA976A5DE86

P407

Q37070077-217BA3A2-7CD7-49C6-ABBF-572927343249

P433

Q37070077-6FF0CA73-2388-41F8-B385-EA9CD1595C74

P478

Q37070077-0E015B1D-5347-4571-8245-47FA93DC8788

P50

Q37070077-0FBF05C5-D124-4E21-8CAF-4A5E07815FE2

Q37070077-13DBDEDC-E4E6-4A19-977C-80AC47E14222

Q37070077-E32EC814-F305-48EE-B044-D2A34ED2D562

P577

Q37070077-D6A9DD09-0554-4F07-9A50-99195FF17352

P698

Q37070077-DD0F7576-7E1E-481C-A8C1-FD23F9953AFC

P921

Q37070077-BE953014-49DA-4840-B7EB-9B0C3E1C2134

P932

Q37070077-7310FE99-5FE0-47A1-A9EC-79FF89AADD6B

P356

RCCM.201205-0880OC

P1433

American Journal of Respiratory and Critical Care Medicine

P1476

Diminazene attenuates pulmonar ...... nctions in experimental models

@en

P2093

Altin Gjymishka

http://www.w3.org/2001/XMLSchema#string

Anderson J Ferreira

http://www.w3.org/2001/XMLSchema#string

Arturo J Cardounel

http://www.w3.org/2001/XMLSchema#string

Chastity Bradford

http://www.w3.org/2001/XMLSchema#string

Deepmala Agarwal

http://www.w3.org/2001/XMLSchema#string

Dipankar Gupta

http://www.w3.org/2001/XMLSchema#string

Erin Bruce

http://www.w3.org/2001/XMLSchema#string

J Mocco

http://www.w3.org/2001/XMLSchema#string

Jane Yellowlees Douglas

http://www.w3.org/2001/XMLSchema#string

Jawaharlal M Patel

http://www.w3.org/2001/XMLSchema#string

P2860

ACE2: a new target for cardiovascular disease therapeutics

Angiotensin signalling in pulmonary fibrosis

Isolation of putative progenitor endothelial cells for angiogenesis

Diabetic retinopathy is associated with bone marrow neuropathy and a depressed peripheral clock

Prediction of off-target effects on angiotensin-converting enzyme 2.

The angiotensin-converting enzyme 2/angiogenesis-(1-7)/Mas axis confers cardiopulmonary protection against lung fibrosis and pulmonary hypertension.

Evaluation and management of the patient with pulmonary arterial hypertension.

Targeting the ACE2-Ang-(1-7) pathway in cardiac fibroblasts to treat cardiac remodeling and heart failure

Inflammation in pulmonary arterial hypertension.

Regulation of alveolar epithelial cell survival by the ACE-2/angiotensin 1-7/Mas axis.

P304

648-657

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1164/RCCM.201205-0880OC

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

187

http://www.w3.org/2001/XMLSchema#string

P50

Anandharajan Rathinasabapathy

William R Kennedy

P577

2013-01-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23370913

http://www.w3.org/2001/XMLSchema#string

P921

arterial hypertension

P932

3733435

http://www.w3.org/2001/XMLSchema#string